Dr. Marco Taglietti Discusses SCYNEXIS and their Ibrexafungerp Anti-Fungal Drug S2 E31

trialsitenews's podcast

Listen as we talk to Dr. Taglietti about SCYNEXIS and their drug Ibrexafungerp

The press release below talks about their successful meeting with the NDA- https://ir.scynexis.com/press-releases/detail/216/scynexis-reports-successful-completion-of-pre-nda-meetings recently for Ibrexafungerp for the treatment of VVC, the common fungal infection affecting millions of women each year in the U.S.

To view a presentation go here